Aptevo Therapeutics Inc. Weighted Average Number of Shares Outstanding, Basic and Diluted
Aptevo Therapeutics Inc. (APVO) reported Weighted Average Number of Shares Outstanding, Basic and Diluted of 4.94 million shares for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-12.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted · last filed 2022-05-12
- Aptevo Therapeutics Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2022-03-31 was 4.94M shares, a 11.75% increase year-over-year.
- Aptevo Therapeutics Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-12-31 was 4.90M shares, a 26.81% increase year-over-year.
- Aptevo Therapeutics Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-09-30 was 4.89M shares, a 51.32% increase year-over-year.
- Aptevo Therapeutics Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-06-30 was 4.54M shares, a 40.33% increase year-over-year.
- Aptevo Therapeutics Inc. weighted average number of shares outstanding, basic and diluted for fiscal 2021 was 4.69M shares, a 38.25% increase from fiscal 2020.
- Aptevo Therapeutics Inc. weighted average number of shares outstanding, basic and diluted for fiscal 2020 was 3.39M shares, a 16.25% increase from fiscal 2019.
- Aptevo Therapeutics Inc. weighted average number of shares outstanding, basic and diluted for fiscal 2019 was 2.92M shares, a 87.04% decline from fiscal 2018.
- Aptevo Therapeutics Inc. weighted average number of shares outstanding, basic and diluted for fiscal 2018 was 22.50M shares, a 5.46% increase from fiscal 2017.
| Period end | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic and Diluted 6 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 6 month as first filed | Weighted Average Number of Shares Outstanding, Basic and Diluted 9 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 9 month as first filed | Weighted Average Number of Shares Outstanding, Basic and Diluted 12 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2022-03-31 | 4.94M shares 10-Q · filed 2022-05-12 | 4.92M shares derived: average of 2 quarters · filed 2022-05-12 | 4.91M shares derived: average of 3 quarters · filed 2022-05-12 | 4.82M shares derived: average of 4 quarters · filed 2022-05-12 | ||||
| 2021-12-31 | 4.90M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-24 | 4.90M shares derived: average of 2 quarters · filed 2022-03-24 | 4.78M shares derived: average of 3 quarters · filed 2022-03-24 | 4.69M shares 10-K · filed 2022-03-24 | ||||
| 2021-09-30 | 4.89M shares 10-Q · filed 2021-11-12 | 4.71M shares derived: average of 2 quarters · filed 2021-11-12 | 4.62M shares 10-Q · filed 2021-11-12 | 4.43M shares derived: average of 4 quarters · filed 2022-05-12 | ||||
| 2021-06-30 | 4.54M shares 10-Q · filed 2021-08-12 | 4.48M shares 10-Q · filed 2021-08-12 | 4.27M shares derived: average of 3 quarters · filed 2022-05-12 | 4.01M shares derived: average of 4 quarters · filed 2022-05-12 | ||||
| 2021-03-31 | 4.42M shares 10-Q · filed 2022-05-12 | 4.14M shares derived: average of 2 quarters · filed 2022-05-12 | 3.84M shares derived: average of 3 quarters · filed 2022-05-12 | 3.69M shares derived: average of 4 quarters · filed 2022-05-12 | ||||
| 2020-12-31 | 3.86M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-24 | 3.55M shares derived: average of 2 quarters · filed 2022-03-24 | 3.44M shares derived: average of 3 quarters · filed 2022-03-24 | 3.39M shares 10-K · filed 2022-03-24 | ||||
| 2020-09-30 | 3.23M shares 10-Q · filed 2021-11-12 | 3.23M shares derived: average of 2 quarters · filed 2021-11-12 | 3.23M shares 10-Q · filed 2021-11-12 | 3.24M shares derived: average of 4 quarters · filed 2021-11-12 | ||||
| 2020-06-30 | 3.23M shares 10-Q · filed 2021-08-12 | 3.27M shares 10-Q · filed 2021-08-12 | 3.25M shares derived: average of 3 quarters · filed 2021-08-12 | 3.24M shares derived: average of 4 quarters · filed 2021-08-12 | ||||
| 2020-03-31 | 3.27M shares 10-Q · filed 2021-05-11 | 3.25M shares derived: average of 2 quarters · filed 2021-05-11 | 3.24M shares derived: average of 3 quarters · filed 2021-05-11 | 3.24M shares derived: average of 4 quarters · filed 2021-05-11 | ||||
| 2019-12-31 | 3.24M shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | 3.23M shares derived: average of 2 quarters · filed 2021-03-31 | 3.23M shares derived: average of 3 quarters · filed 2021-03-31 | 2.92M shares 10-K · filed 2021-03-31 | 40.84M shares 10-K · filed 2020-03-25 | |||
| 2019-09-30 | 3.23M shares 10-Q · filed 2020-11-10 | 45.17M shares 10-Q · filed 2019-11-07 | 3.22M shares derived: average of 2 quarters · filed 2020-11-10 | 2.81M shares 10-Q · filed 2020-11-10 | 39.34M shares 10-Q · filed 2019-11-07 | 7.68M shares derived: average of 4 quarters · filed 2020-11-10 | ||
| 2019-06-30 | 3.22M shares 10-Q · filed 2020-08-14 | 45.10M shares 10-Q · filed 2019-08-09 | 2.60M shares 10-Q · filed 2020-08-14 | 36.38M shares 10-Q · filed 2019-08-09 | 9.17M shares derived: average of 3 quarters · filed 2020-08-14 | 12.54M shares derived: average of 4 quarters · filed 2020-08-14 | ||
| 2019-03-31 | 1.57M shares 10-Q · filed 2020-05-13 | 27.57M shares 10-Q · filed 2019-05-09 | 12.14M shares derived: average of 2 quarters · filed 2020-05-13 | 15.65M shares derived: average of 3 quarters · filed 2020-05-13 | 17.39M shares derived: average of 4 quarters · filed 2020-05-13 | |||
| 2018-12-31 | 22.71M shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-25 | 22.69M shares derived: average of 2 quarters · filed 2020-03-25 | 22.66M shares derived: average of 3 quarters · filed 2020-03-25 | 22.50M shares 10-K · filed 2020-03-25 | ||||
| 2018-09-30 | 22.67M shares 10-Q · filed 2019-11-07 | 22.63M shares derived: average of 2 quarters · filed 2019-11-07 | 22.43M shares 10-Q · filed 2019-11-07 | |||||
| 2018-06-30 | 22.59M shares 10-Q · filed 2019-08-09 | 22.31M shares 10-Q · filed 2019-08-09 | ||||||
| 2018-03-31 | 22.03M shares 10-Q · filed 2019-05-09 | |||||||
| 2017-12-31 | 21.34M shares 10-K · filed 2019-03-18 | |||||||
| 2017-06-30 | 21.27M shares 10-Q · filed 2017-08-10 | 21.01M shares 10-Q · filed 2017-08-10 | 20.76M shares derived: average of 3 quarters · filed 2018-03-13 | 20.63M shares derived: average of 4 quarters · filed 2018-03-13 | ||||
| 2017-03-31 | 20.76M shares 10-Q · filed 2017-05-12 | 20.51M shares derived: average of 2 quarters · filed 2018-03-13 | 20.42M shares derived: average of 3 quarters · filed 2018-03-13 | 20.37M shares derived: average of 4 quarters · filed 2018-03-13 | ||||
| 2016-12-31 | 20.26M shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-13 | 20.25M shares derived: average of 2 quarters · filed 2018-03-13 | 20.24M shares derived: average of 3 quarters · filed 2018-03-13 | 20.24M shares 10-K · filed 2018-03-13 | ||||
| 2016-09-30 | 20.24M shares 10-Q · filed 2016-11-14 | 20.23M shares derived: average of 2 quarters · filed 2017-08-10 | 20.23M shares 10-Q · filed 2016-11-14 | 20.23M shares derived: average of 4 quarters · filed 2017-08-10 | ||||
| 2016-06-30 | 20.23M shares 10-Q · filed 2017-08-10 | 20.23M shares 10-Q · filed 2017-08-10 | 20.23M shares derived: average of 3 quarters · filed 2017-08-10 | 20.23M shares derived: average of 4 quarters · filed 2017-08-10 | ||||
| 2016-03-31 | 20.23M shares 10-Q · filed 2017-05-12 | 20.23M shares derived: average of 2 quarters · filed 2017-05-12 | 20.23M shares derived: average of 3 quarters · filed 2017-05-12 | 20.23M shares derived: average of 4 quarters · filed 2017-05-12 | ||||
| 2015-12-31 | 20.23M shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-31 | 20.23M shares derived: average of 2 quarters · filed 2017-03-31 | 20.23M shares derived: average of 3 quarters · filed 2017-03-31 | 20.23M shares 10-K · filed 2017-03-31 | ||||
| 2015-09-30 | 20.23M shares 10-Q · filed 2016-11-14 | 20.23M shares derived: average of 2 quarters · filed 2016-11-14 | 20.23M shares 10-Q · filed 2016-11-14 | |||||
| 2015-06-30 | 20.23M shares 10-Q/A · filed 2016-09-22 | 20.23M shares 10-Q/A · filed 2016-09-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B |